Parker & Waichman Calls for Immediate Recall of Serzone from U.S. Market, Firm Does Not Believe Bristol Myers Squibb's Plan to Stop Shipment of Drug on June 14, 2004 Adequately Protects U.S. Patients NEW YORK, May 20, 2004 (PRIMEZONE) -- Parker & Waichman LLP (www.yourlawyer.com) is calling on Bristol Myers Squibb (NYSE:BMY) to immediately stop the sale of Serzone by formally recalling the...